The authors commented that the patient’s "age, relative acute onset, and lack of medical history make this an atypical ...

Retinal disorders can significantly impact vision ... Dexamethasone implant is also used to reduce macular edema. In more advanced cases, vitrectomy may be required. This surgical procedure ...

In fact, macular edema is the most common cause of loss of ... target human monoclonal antibodies that could be used to treat retinal diseases. Basically, KOD will gain access to Nona's technology ...

diabetic macular edema (DME) is a vision-threatening retinal condition associated with blindness and decreased quality of life when left untreated. DME occurs when damaged blood vessels in the ...

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced their abstract of a preclinical study of KIO ...

India is home to one-third of the world’s blind population, with over 11 million affected by retinal conditions, including ...

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced ...

MOUNTAIN VIEW, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for ...

A live webcast and subsequent archived replay of each presentation may be accessed via the Investors section of the Company website at www.eyepointpharma.com.